# FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

> **NCT03718923** · — · RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 50 (estimated)

## Conditions studied

- FOXP1
- Mental Retardation With Language Impairment and With or Without Autistic Features
- Autism Spectrum Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03718923
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2016-03-28
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-04-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03718923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03718923, "FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03718923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*